RANDOMIZED TRIAL OF CHLOROZOTOCIN, NEOCARZINOSTATIN, OR METHYL-CCNU IN PATIENTS WITH MALIGNANT-MELANOMA

被引：8
|
作者：
VONHOFF, DD
AMATO, DA
KAUFMAN, JH
FALKSON, G
CUNNINGHAM, TJ
机构：
[1] NCI,BETHESDA,MD 20205
[2] SIDNEY FARBER CANC INST,BOSTON,MA 02115
[3] HOSP UNIV PENN,PHILADELPHIA,PA 19104
[4] UNIV PRETORIA,PRETORIA,SOUTH AFRICA
[5] UNION UNIV ALBANY MED COLL,ALBANY,NY 12208
来源：
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1984年 / 7卷 / 02期
关键词：
D O I：
10.1097/00000421-198404000-00006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：135 / 139
页数：5
相关论文
共 50 条
  • [1] METHYL-CCNU ADJUVANT CHEMOTHERAPY OF MALIGNANT-MELANOMA IS NOT IMMUNOSUPPRESSIVE
    BERD, D
    WILSON, E
    BELLET, RE
    MASTRANGELO, MJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 349 - 349
  • [2] IMMUNO-CHEMOTHERAPY OF DISSEMINATED MALIGNANT-MELANOMA STAGE .3. RANDOMIZED TRIAL COMPARING METHYL-CCNU VERSUS CORYNEBACTERIUM PARVUM PLUS METHYL-CCNU
    KOKOSCHKA, EM
    LUGER, T
    MICKSCHE, M
    ONKOLOGIE, 1978, 1 (03): : 98 - 103
  • [3] RANDOMIZED PROSPECTIVE TRIAL COMPARING METHYL-CCNU VINCRISTINE WITH METHYL-CCNU+VINCRISTINE+BCG+AKKIGEBEUC TUMOR-CELLS IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA
    MASTRANGELO, MJ
    BELLET, RE
    BERD, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 319 - 319
  • [4] METHYL-CCNU IN MALIGNANT-MELANOMA - DIVIDED DOSE SCHEDULE OF ADMINISTRATION
    WITTES, RE
    HONG, WK
    GATCHELL, L
    KRAKOFF, IH
    GOLBEY, RB
    ONCOLOGY, 1977, 34 (01) : 45 - 46
  • [5] NEPHROTOXICITY OF SEMUSTINE (METHYL-CCNU) IN PATIENTS WITH MALIGNANT-MELANOMA RECEIVING ADJUVANT CHEMOTHERAPY
    MICETICH, KC
    JENSENAKULA, M
    MANDARD, JC
    FISHER, RI
    AMERICAN JOURNAL OF MEDICINE, 1981, 71 (06): : 967 - 972
  • [6] COMBINATION CHEMOTHERAPY FOR DISSEMINATED MALIGNANT-MELANOMA WITH DTIC, VINCRISTINE, AND METHYL-CCNU
    EINHORN, LH
    FURNAS, B
    CANCER TREATMENT REPORTS, 1977, 61 (05): : 881 - 883
  • [7] RANDOMIZED TRIAL OF CHLORPROMAZINE, CAFFEINE, AND METHYL-CCNU IN DISSEMINATED MELANOMA
    COHEN, MH
    SCHOENFELD, D
    WOLTER, J
    CANCER TREATMENT REPORTS, 1980, 64 (01): : 151 - 153
  • [8] RANDOMIZED PROSPECTIVE PHASE-III TRIAL OF METHYL-CCNU (NSC-95441) ALONE VERSUS METHYL-CCNU PLUS VINCRISTINE (NSC-67574) IN TREATMENT OF PATIENTS WITH METASTATIC MALIGNANT-MELANOMA
    BELLET, RE
    MASTRANGELO, MJ
    BERD, D
    LUSTBADER, E
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 284 - 284
  • [9] USE OF METHYL-CCNU AND PROCARBAZINE IN ADVANCED MALIGNANT-MELANOMA RESISTANT TO DTIC THERAPY
    DIDOLKAR, MS
    BAFFI, RR
    CATANE, R
    KAUFMAN, J
    HOLYOKE, ED
    CANCER TREATMENT REPORTS, 1977, 61 (09): : 1738 - 1739
  • [10] TREATMENT OF MALIGNANT-MELANOMA WITH METHYL CCNU
    YOUNG, RC
    CANELLOS, GP
    CHABNER, BA
    SCHEIN, PS
    BRERETON, HD
    DEVITA, VT
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1974, 15 (06) : 617 - 622
12345